SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Starlight who wrote (5438)1/30/1998 4:51:00 PM
From: aknahow  Read Replies (3) | Respond to of 17367
 
Bety, thanks for the info. Wonder how My Mother gets this info on 6 deaths out of 135 treated. Not saying I wouldn't want to get the info myself from hospitals involved as someone sugested, but if this is coming from XOMA to him I am pissed. Why would they tell us they can't release it and then tell Murphy.

Even so I hope info is true. But as Robert K might point out the deaths might have all come from the non placebo group so we won't know until its all over. Even so if 67 were in the treated group and all the deaths occured in the other, non treated or placebo group the percentage of deaths seems low. Thats wonderful for the sick kids but makes me wonder if M.M. has his numbers right. Sort of remember he threw out a number right before XOMA announced they were not supposed to announce total deaths. Anyway thanks again.



To: Starlight who wrote (5438)1/30/1998 5:23:00 PM
From: Pseudo Biologist  Read Replies (1) | Respond to of 17367
 
Thanks Betty. Without knowing much about CORR, the 50% drop yesterday seemed too drastic. Was a tough two days for the newsletter gurus. First, favorite long CORR gets a wishy-washy FDA approval; then, favorite short ORG (by Sturza, as I understand) gets approval. Who said this stuff was easy?

PB